Hyperphosphatemia Clinical Trials
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Recruiting
- Anemia, Iron Deficiency
- +6 more
- Ferric Citrate 1 GM Oral Tablet [AURYXIA]
- Placebo
- Dalton, GeorgiaNephrology and Hypertension Specialists, PC
2022-03-30
Mar 30, 2022U
Active, not recruiting
- Hyperphosphatemia
- +2 more
- Ferric Citrate 1 gram Oral Tablet
- Standard of care phosphate-lowering therapy
- Anchorage, Alaska
- +12 more
2022-03-30
Mar 30, 2022S
Completed
- Hyperphosphatemia
- Placebo
- Sevelamer Carbonate (GZ419831)
- Beijing, China
- +37 more
2022-03-15
Mar 15, 2022S
Active, not recruiting
- Hyperphosphatemia
- VS-505
- Sevelamer Carbonate
- Beijing, Beijing, China
- +22 more
2022-03-22
Mar 22, 2022T
Recruiting
- Kidney Failure, Chronic
- Hyperphosphatemia
- Liberal phosphate target
- Intensive phosphate target
- Camperdown, New South Wales, Australia
- +48 more
2022-02-28
Feb 28, 2022K
Completed
- Hyperphosphatemia
- +3 more
- Parenteral Nutrition (PN) Premixed Olimel N9E
- Riyadh, Saudi ArabiaKing Faisal Specialist Hospital & Research Centre
2022-02-02
Feb 2, 2022K
Completed
- Hyperphosphatemia
- Ferric Citrate
- Los Angeles, CaliforniaKaiser Permanente Los Angeles Medical Center
2022-01-03
Jan 3, 2022K
Completed
- Hyperphosphatemia
- Suita, Osaka, JapanInoue Hospital
2022-01-07
Jan 7, 2022A
Completed
- Hyperphosphatemia
- End Stage Renal Disease
- Tenapanor
- Sevelamer Carbonate
- Houston, CaliforniaArdelyx Site #509
2022-01-05
Jan 5, 2022A
Active, not recruiting
- Chronic Kidney Disease Requiring Chronic Dialysis
- Hyperphosphatemia
- Lauderdale Lakes, FloridaSouth Florida Research Institute
2022-01-05
Jan 5, 2022B
Active, not recruiting
- Chronic Kidney Disease(CKD)
- +2 more
- Intervention group; NNRD group
- Copenhagen, DenmarkRigshospitalet
2021-12-15
Dec 15, 2021D
Recruiting
- Coronavirus Infection (COVID-19)
- +24 more
- The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:
- Phoenix, Arizona
- +48 more
2021-12-01
Dec 1, 2021K
U
Completed
- Peritoneal Dialysis Complication
- +2 more
- Sucroferric Oxyhydroxide Chewable Tablet
- Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
2021-10-08
Oct 8, 2021K
Completed
- Hyperphosphatemia
- KHK7791
- Placebo
- Tsukuba, Ibaraki, JapanKikuchi medical clinic
2021-09-07
Sep 7, 2021K
Active, not recruiting
- Hyperphosphatemia
- Kanoya, Kagoshima, JapanMedical Corporation Seijinkai Ikeda Hospital
2021-09-07
Sep 7, 2021C
Completed
- Maintenance Hemodialysis
- Hyperphosphatemia
- Phosphate-binder intervention
- Phosphorus-restricted dietary intervention
- Shanghai, Shanghai, China
- +1 more
2021-08-25
Aug 25, 2021G
Recruiting
- Hyperphosphatemia
- Lanthanum Polystyrene Sulphonate Powder
- +2 more
- Changchun, Jilin, ChinaThe First Hospital of Jilin University
2021-07-27
Jul 27, 2021S
Completed
- Hyperphosphatemia
- Lanthanum carbonate
- Lynwood, California
- +18 more
2021-06-21
Jun 21, 2021V
Completed
- Chronic Kidney Disease Requiring Chronic Dialysis
- Hyperphosphatemia
- PA21
- sevelamer carbonate
- Guangzhou, Guangdong, ChinaSouthern Medical University Nanfang Hospital
2021-05-31
May 31, 2021S
Completed
- Hyperphosphatemia
- Birmingham, Alabama
- +198 more
2021-03-16
Mar 16, 2021T
Completed
- Hyperphosphatemia
- End Stage Renal Disease on Dialysis
- Phosphate mobile app
- One-off dietary counselling with a phosphate booklet
- Batu Caves, Selangor, Malaysia
- +2 more
2021-03-08
Mar 8, 2021P
Completed
- Hyperphosphatemia
- +2 more
- Ferric Citrate
- Sevelamer Carbonate
- Baotou, China
- +23 more
2021-03-08
Mar 8, 2021O
Enrolling by invitation
- Renal Insufficiency, Chronic
- +2 more
- Lanthanum carbonate
- Calcium Carbonate
- Suita, Osaka, JapanOsaka University Hospital
2021-02-24
Feb 24, 2021N
Completed
- Hyperphosphatemia
- Chronic Kidney Disease
- Jette, Belgium
- +8 more
2020-12-11
Dec 11, 2020